Abstract
We present an alternative production platform for the synthesis of complex proteins. Apart from conventionally applied protein production using engineered mammalian cell lines, this protocol describes the preparation and principle of cell-free protein synthesis systems based on CHO cell lysates. The CHO cell-free system contains endogenous microsomes derived from the endoplasmic reticulum, which enables a direct integration of membrane proteins into a nature like milieu and the introduction of posttranslational modifications. Different steps of system development are described including the cultivation of CHO cells, cell harvesting and cell disruption to prepare translationally active CHO cell lysates. The requirements for DNA templates and the generation of linear DNA templates suitable for the CHO cell-free reaction is further depicted to underline the opportunity to produce different protein variants in a short period. This experimental setup provides a basis for high-throughput applications. The productivity of the CHO cell-free systems is further increased by using a non-canonical translation initiation due to the attachment of an internal ribosomal entry site of the Cricket paralysis virus (CRPV IRES) to the 5´ UTR of the desired gene. In this way, a direct interaction of the IRES structure with the ribosome facilitates a translation factor independent initiation of translation. Cell-free reactions were performed in fast and efficient batch reactions leading to protein yields up to 40μg/mL. The reaction format was further adjusted to a continuous exchange CHO cell-free reaction (CHO CECF) to prolong reaction time and thereby increase the productivity of the cell-free systems. Finally, protein yields up to 1g/L were obtained. The CHO CECF system represents a sophisticated resource to address structural and functional aspects of difficult-to-express proteins in fundamental and applied research.
Highlights
Nowadays, protein synthesis plays a pivotal role in the pharmaceutical industry for the development and screening of novel therapeutical treatments and the production of drugs
Special eukaryotic cell-free systems contain endogenous microsomes derived from the endoplasmic reticulum due to a mild cell disruption procedure during lysate preparation
In order to combine a mammalian host cell often used for the production of versatile, mammalian proteins and a cell-free platform, we have recently developed novel systems based on the prominent industrial protein production host Chinese hamster ovary (CHO) cells [15, 16]
Summary
Protein synthesis plays a pivotal role in the pharmaceutical industry for the development and screening of novel therapeutical treatments and the production of drugs. Despite their challenging production process, these proteins harbor a high potential for pharmaceutical applications [5, 6] In this context, novel protein productions platforms so called cell-free protein synthesis systems are continuously developed to provide a value-added technology. The fast, efficient, and high-throughput compatible protein synthesis tool promotes DNA template pre-evaluation as well as production of difficult-to-express proteins [17] To realize these demands a coupled transcription/translation system is developed containing endogenous microsomal structures for posttranslational modifications and cotranslational membrane protein integration. This chapter includes an overview covering the entire process pipeline for the development of CHO cell-free systems In this protocol, we present the preparation of cell-free systems containing the cultivation of CHO cells, the preparation of translationally active lysate, the generation of linear expression templates and the cell-free production of proteins using batch and CECF formatted systems
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.